Amalgamated Bank’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $246K | Buy |
|
|||||
|
2025
Q1 | $223K | Buy |
|
|||||
|
2024
Q4 | $251K | Buy |
|
|||||
|
2024
Q3 | $328K | Hold |
|
|||||
|
2024
Q2 | $242K | Buy |
|
|||||
|
2024
Q1 | $243K | Sell |
|
|||||
|
2023
Q4 | $752K | Buy |
|
|||||
|
2023
Q3 | $509K | Sell |
|
|||||
|
2023
Q2 | $678K | Buy |
|
|||||
|
2023
Q1 | $535K | Sell |
|
|||||
|
2022
Q4 | $680K | Buy |
|
|||||
|
2022
Q3 | $597K | Buy |
|
|||||
|
2022
Q2 | $852K | Buy |
|
|||||
|
2022
Q1 | $1.03M | Buy |
|
|||||
|
2021
Q4 | $1.11M | Buy |
|
|||||
|
2021
Q3 | $1.05M | Sell |
|
|||||
|
2021
Q2 | $1.18M | Buy |
|
|||||
|
2021
Q1 | $1.03M | Sell |
|
|||||
|
2020
Q4 | $1.35M | Buy |
|
|||||
|
2020
Q3 | $735K | Sell |
|
|||||
|
2020
Q2 | $710K | Sell |
|
|||||
|
2020
Q1 | $443K | Sell |
|
|||||
|
2019
Q4 | $454K | Buy |
|
|||||
|
2019
Q3 | $414K | Sell |
|
|||||
|
2019
Q2 | $622K | Buy |
|
|||||
|
2019
Q1 | $557K | Buy |
|
|||||
|
2018
Q4 | $299K | Buy |
|
|||||
|
2018
Q3 | $210K | Sell |
|
|||||
|
2018
Q2 | $552K | Buy |
|
|||||
|
2018
Q1 | $303K | Buy |
|
|||||
|
2017
Q4 | $250K | Buy |
|
|||||
|
2017
Q3 | $268K | Buy |
|
|||||
|
2017
Q2 | $309K | Buy |
|
|||||
|
2017
Q1 | $314K | Buy |
|
|||||
|
2016
Q4 | $311K | Buy |
|
|||||
|
2016
Q3 | $270K | Buy |
|
|||||
|
2016
Q2 | $260K | Sell |
|
|||||
|
2016
Q1 | $256K | Buy |
|
|||||
|
2015
Q4 | $414K | Sell |
|
|||||
|
2015
Q3 | $388K | Buy |
|
|||||
|
2015
Q2 | $380K | Buy |
|